Philips settles US sleep machine cases for $1.1 billion
29 Apr 2024
Philips has been battling a series of crises since 2021 over its DreamStation machines for sleep apnoea, a disorder in which breathing intermittently stops during sleep. Earlier this year, it decided to halt new sales of the machines made by subsidiary Philips Respironics in the United States following a series of recalls.